Bausch Health Companies Inc. Payments to Noncontrolling Interests
Bausch Health Companies Inc. (BHC) reported Payments to Noncontrolling Interests of $18.00 million for the 12-month period ending 2017-12-31, per its 8-K filed 2018-08-10.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:PaymentsToMinorityShareholders · last filed 2018-08-10
- Bausch Health Companies Inc. payments to noncontrolling interests for the quarter ending 2014-06-30 was $0.00.
- Bausch Health Companies Inc. payments to noncontrolling interests for the quarter ending 2014-03-31 was $3.30M.
- Bausch Health Companies Inc. payments to noncontrolling interests for the quarter ending 2013-12-31 was -$1.00K, a 100.03% decline year-over-year.
- Bausch Health Companies Inc. payments to noncontrolling interests for the quarter ending 2013-09-30 was $2.10M.
- Bausch Health Companies Inc. payments to noncontrolling interests for fiscal 2014 was $8.00M, a 280.95% increase from fiscal 2013.
- Bausch Health Companies Inc. payments to noncontrolling interests for fiscal 2013 was $2.10M, a 47.50% decline from fiscal 2012.
- Bausch Health Companies Inc. payments to noncontrolling interests for fiscal 2012 was $4.00M.
- Bausch Health Companies Inc. payments to noncontrolling interests for fiscal 2011 was $0.00.
| Period end | Payments to Noncontrolling Interests 3 month | Payments to Noncontrolling Interests 6 month | Payments to Noncontrolling Interests 9 month | Payments to Noncontrolling Interests 12 month | Payments to Noncontrolling Interests 12 month as first filed |
|---|---|---|---|---|---|
| 2017-12-31 | $18.00M 8-K · filed 2018-08-10 | ||||
| 2016-12-31 | $9.00M 8-K · filed 2018-08-10 | ||||
| 2015-12-31 | $9.00M 8-K · filed 2018-08-10 | $8.30M 10-K · filed 2016-04-29 | |||
| 2014-12-31 | $8.00M 10-K · filed 2017-03-01 | $8.20M 10-K · filed 2015-02-25 | |||
| 2014-06-30 | $0.00 10-Q · filed 2014-08-01 | $3.30M 10-Q · filed 2014-08-01 | $3.30M derived: sum of 3 quarters · filed 2016-04-29 | $5.40M derived: sum of 4 quarters · filed 2016-04-29 | |
| 2014-03-31 | $3.30M 10-Q · filed 2014-05-09 | $3.30M derived: sum of 2 quarters · filed 2016-04-29 | $5.40M derived: sum of 3 quarters · filed 2016-04-29 | $5.40M derived: sum of 4 quarters · filed 2016-04-29 | |
| 2013-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-04-29 | $2.10M derived: sum of 2 quarters · filed 2016-04-29 | $2.10M derived: sum of 3 quarters · filed 2016-04-29 | $2.10M 10-K · filed 2016-04-29 | $2.10M 10-K · filed 2014-02-28 |
| 2013-09-30 | $2.10M 10-Q · filed 2013-11-01 | $2.10M derived: sum of 2 quarters · filed 2014-08-01 | $2.10M 10-Q · filed 2013-11-01 | $6.10M derived: sum of 4 quarters · filed 2015-02-25 | |
| 2013-06-30 | $0.00 10-Q · filed 2014-08-01 | $0.00 10-Q · filed 2014-08-01 | $4.00M derived: sum of 3 quarters · filed 2015-02-25 | $4.00M derived: sum of 4 quarters · filed 2015-02-25 | |
| 2013-03-31 | $0.00 10-Q · filed 2014-05-09 | $4.00M derived: sum of 2 quarters · filed 2015-02-25 | $4.00M derived: sum of 3 quarters · filed 2015-02-25 | ||
| 2012-12-31 | $4.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | $4.00M derived: sum of 2 quarters · filed 2015-02-25 | $4.00M 10-K · filed 2015-02-25 | $0.00 10-K · filed 2014-02-28 | |
| 2012-09-30 | $0.00 10-Q · filed 2013-11-01 | $0.00 10-Q · filed 2013-11-01 | |||
| 2011-12-31 | -$28.52M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $0.00 derived: sum of 2 quarters · filed 2014-02-28 | $0.00 10-K · filed 2014-02-28 | $52.50M 10-K · filed 2012-02-29 | |
| 2011-09-30 | $28.52M 10-Q · filed 2012-11-05 | $28.52M 10-Q · filed 2012-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |